{"transactions":[{"id":692096,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":195776,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of June 17, 2027. The principal amount of the convertible note together with any accrued but unpaid interest automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering at a conversion price equal to the initial public offering price of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of June 17, 2027. The principal amount of the convertible note together with any accrued but unpaid interest automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering at a conversion price equal to the initial public offering price of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of June 17, 2027. The principal amount of the convertible note together with any accrued but unpaid interest automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering at a conversion price equal to the initial public offering price of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of June 17, 2027. The principal amount of the convertible note together with any accrued but unpaid interest automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering at a conversion price equal to the initial public offering price of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":195776},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692095,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":296880,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held of record by Foresite Capital Opportunity Fund V, L.P. (Opportunity Fund V). Foresite Capital Opportunity Management V, LLC (FCOM V) is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over the shares held by Opportunity Fund V. The Reporting Person is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over the securities held by Opportunity Fund V. Each of Opportunity Fund V, FCOM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":296880},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692094,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":3117664,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held of record by Foresite Capital Opportunity Fund V, L.P. (Opportunity Fund V). Foresite Capital Opportunity Management V, LLC (FCOM V) is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over the shares held by Opportunity Fund V. The Reporting Person is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over the securities held by Opportunity Fund V. Each of Opportunity Fund V, FCOM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3117664},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692093,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":742201,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":742201},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692092,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":1125823,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1125823},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692091,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":445320,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Foresite Capital Fund V, L.P. (Fund V). Foresite Capital Management V, LLC (FCM V) is the general partner of Fund V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. The Reporting Person is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. Each of Fund V, FCM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":445320},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692090,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":3117664,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Foresite Capital Fund V, L.P. (Fund V). Foresite Capital Management V, LLC (FCM V) is the general partner of Fund V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. The Reporting Person is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. Each of Fund V, FCM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3117664},"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692089,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":296880,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held of record by Foresite Capital Opportunity Fund V, L.P. (Opportunity Fund V). Foresite Capital Opportunity Management V, LLC (FCOM V) is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over the shares held by Opportunity Fund V. The Reporting Person is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over the securities held by Opportunity Fund V. Each of Opportunity Fund V, FCOM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":3414544,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692088,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":3117664,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held of record by Foresite Capital Opportunity Fund V, L.P. (Opportunity Fund V). Foresite Capital Opportunity Management V, LLC (FCOM V) is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over the shares held by Opportunity Fund V. The Reporting Person is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over the securities held by Opportunity Fund V. Each of Opportunity Fund V, FCOM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":3117664,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692087,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":195776,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of June 17, 2027. The principal amount of the convertible note together with any accrued but unpaid interest automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering at a conversion price equal to the initial public offering price of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":2203800,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692086,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"purchase","planned":false,"acquired":true,"shares":140000,"price":18,"value":2520000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":2008024,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692085,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":742201,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":1868024,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692084,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":1125823,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Foresite Capital Fund VI, LP (Fund VI). Foresite Capital Management VI, LLC (FCM VI) is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. The Reporting Person is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of Fund VI, FCM VI and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":1125823,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692083,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":445320,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Foresite Capital Fund V, L.P. (Fund V). Foresite Capital Management V, LLC (FCM V) is the general partner of Fund V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. The Reporting Person is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. Each of Fund V, FCM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":3562984,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":692082,"issuer":{"id":4709,"kind":"organization","name":"Latigo Biotherapeutics, Inc."},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T00:00:09.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":3117664,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Foresite Capital Fund V, L.P. (Fund V). Foresite Capital Management V, LLC (FCM V) is the general partner of Fund V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. The Reporting Person is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. Each of Fund V, FCM V and the Reporting Person disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":3117664,"source":{"system":"sec-edgar","filing":"0001581754-26-000006","document":"form4-08102026_080804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056611/000158175426000006/form4-08102026_080804.xml","form_type":"4"}},{"id":816694,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T19:53:34.000Z","date":"2026-04-01","kind":"other","planned":false,"acquired":true,"shares":680486,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents shares received by TFL Investment Holdings, LLC (\"TFL\") pursuant to pro rata distributions by Labs, for no consideration, to its members in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held of record by TFL. Tananbaum is the manager of TFL, and James B. Tananbaum and Dana Shonfeld Tananbaum Family Trust, of which Tananbaum is a trustee, is the sole member of TFL."}],"balance_after":680486,"source":{"system":"sec-edgar","filing":"0001104659-26-039609","document":"tm2611109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465926039609/tm2611109-1_4seq1.xml","form_type":"4"}},{"id":816693,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T19:53:34.000Z","date":"2026-04-01","kind":"other","planned":false,"acquired":false,"shares":1123337,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata, in-kind distribution, and not a purchase or sale, without additional consideration by Labs to its members in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Labs. Tananbaum, a manager of Labs, may be deemed to share voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs, except to the extent of his pecuniary interest in such securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-039609","document":"tm2611109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465926039609/tm2611109-1_4seq1.xml","form_type":"4"}},{"id":816692,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T19:53:34.000Z","date":"2026-04-01","kind":"other","planned":false,"acquired":true,"shares":1123337,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares received by Labs pursuant to pro rata distributions by Labs Affiliates, for no consideration, to its members in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Labs. Tananbaum, a manager of Labs, may be deemed to share voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs, except to the extent of his pecuniary interest in such securities."}],"balance_after":1123337,"source":{"system":"sec-edgar","filing":"0001104659-26-039609","document":"tm2611109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465926039609/tm2611109-1_4seq1.xml","form_type":"4"}},{"id":816691,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T19:53:34.000Z","date":"2026-04-01","kind":"other","planned":false,"acquired":false,"shares":1176470,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata, in-kind distribution, and not a purchase or sale, without additional consideration by Foresite Labs Affiliates 2021, LLC (\"Labs Affiliates\") to its members in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Labs Affiliates. Foresite Labs, LLC (\"Labs\") is the managing member of Labs Affiliates and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), a manager of Labs, may be deemed to share voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Affiliates, except to the extent of his pecuniary interest in such securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-039609","document":"tm2611109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465926039609/tm2611109-1_4seq1.xml","form_type":"4"}},{"id":941105,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T02:58:06.000Z","date":"2026-01-08","kind":"purchase","planned":false,"acquired":true,"shares":294117,"price":17,"value":4999989.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2908332,"source":{"system":"sec-edgar","filing":"0001104659-26-003016","document":"tm263003-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465926003016/tm263003-1_4seq1.xml","form_type":"4"}},{"id":941104,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T02:58:06.000Z","date":"2026-01-08","kind":"purchase","planned":false,"acquired":true,"shares":117647,"price":17,"value":1999999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":5702536,"source":{"system":"sec-edgar","filing":"0001104659-26-003016","document":"tm263003-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465926003016/tm263003-1_4seq1.xml","form_type":"4"}},{"id":988804,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T21:02:11.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":72212,"price":7.38,"value":532924.56,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2614215,"source":{"system":"sec-edgar","filing":"0001104659-25-115950","document":"tm2532081-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925115950/tm2532081-2_4seq1.xml","form_type":"4"}},{"id":993961,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:51:24.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":190500,"price":6.56,"value":1249680.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2542003,"source":{"system":"sec-edgar","filing":"0001104659-25-114266","document":"tm2531789-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925114266/tm2531789-1_4seq1.xml","form_type":"4"}},{"id":993960,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:51:24.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":117374,"price":6.19,"value":726545.06,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2351503,"source":{"system":"sec-edgar","filing":"0001104659-25-114266","document":"tm2531789-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925114266/tm2531789-1_4seq1.xml","form_type":"4"}},{"id":993959,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:51:24.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":5.59,"value":838500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2234129,"source":{"system":"sec-edgar","filing":"0001104659-25-114266","document":"tm2531789-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925114266/tm2531789-1_4seq1.xml","form_type":"4"}},{"id":993958,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:51:24.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":5.6,"value":280000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2084129,"source":{"system":"sec-edgar","filing":"0001104659-25-114266","document":"tm2531789-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925114266/tm2531789-1_4seq1.xml","form_type":"4"}},{"id":1157463,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-07T01:48:59.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.34,"value":86800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":4247670,"source":{"system":"sec-edgar","filing":"0001104659-25-045222","document":"tm2514241-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925045222/tm2514241-3_4seq1.xml","form_type":"4"}},{"id":1157462,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-07T01:48:59.000Z","date":"2025-05-02","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":4.62,"value":115500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":4227670,"source":{"system":"sec-edgar","filing":"0001104659-25-045222","document":"tm2514241-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925045222/tm2514241-3_4seq1.xml","form_type":"4"}},{"id":1460259,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":681598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Labs Fund I, L.P. (\"Labs Fund I\"). Foresite Labs Management I, LLC (\"FLM I\") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":681598},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460258,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1703998,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1703998},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460257,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":681598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":681598},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460256,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1022398,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1022398},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460255,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":311172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Labs Fund I, L.P. (\"Labs Fund I\"). Foresite Labs Management I, LLC (\"FLM I\") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":311172},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460254,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":311172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":311172},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460253,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":311172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":311172},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460252,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":622344,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":622344},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460251,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":967567,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Labs Fund I, L.P. (\"Labs Fund I\"). Foresite Labs Management I, LLC (\"FLM I\") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":967567},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460250,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":560076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":560076},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460249,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":560076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":560076},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460248,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":481283,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":481283},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460247,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1122994,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1122994},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460246,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":194459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Labs Co-Invest V, LLC (\"Labs Co-Invest\"). FCM V is the managing member of Labs Co-Invest and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Co-Invest, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":194459},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460245,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Redeemable Convertible Preferred Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1944577,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1944577},"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460244,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":2187500,"price":16,"value":35000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":4202670,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460243,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1703998,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2015170,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460242,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":311172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by Foresite Capital Fund VI, L.P. (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":311172,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460241,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":681598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Labs Fund I, L.P. (\"Labs Fund I\"). Foresite Labs Management I, LLC (\"FLM I\") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1960337,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460240,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":311172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Labs Fund I, L.P. (\"Labs Fund I\"). Foresite Labs Management I, LLC (\"FLM I\") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1278739,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460239,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":967567,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Labs Fund I, L.P. (\"Labs Fund I\"). Foresite Labs Management I, LLC (\"FLM I\") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":967567,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460238,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":681598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":2034129,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460237,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":311172,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1352531,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460236,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":560076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1041359,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460235,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":481283,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":481283,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460234,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":194459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Labs Co-Invest V, LLC (\"Labs Co-Invest\"). FCM V is the managing member of Labs Co-Invest and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Co-Invest, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":194459,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460233,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":5584889,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460232,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1022398,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":5272389,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460231,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":622344,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":4249991,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460230,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":560076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":3627647,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460229,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1122994,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":3067571,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1460228,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-04T01:30:10.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1944577,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1944577,"source":{"system":"sec-edgar","filing":"0001104659-24-077875","document":"tm2418840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465924077875/tm2418840-1_4seq1.xml","form_type":"4"}},{"id":1546818,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T16:55:52.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":8.38,"expiration_date":"2032-02-11","underlying":"Common Stock","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0001415889-24-010434","document":"form4-04052024_040433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010434/form4-04052024_040433.xml","form_type":"4"}},{"id":1546817,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T16:55:52.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40501,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was cancelled  pursuant to the Merger Agreement in exchange for one CVR for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":20,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":40501},"source":{"system":"sec-edgar","filing":"0001415889-24-010434","document":"form4-04052024_040433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010434/form4-04052024_040433.xml","form_type":"4"}},{"id":1546816,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T16:55:52.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":520711,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for (i) $2.5879 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010434","document":"form4-04052024_040433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010434/form4-04052024_040433.xml","form_type":"4"}},{"id":1546815,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T16:55:52.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3525957,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for (i) $2.5879 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010434","document":"form4-04052024_040433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010434/form4-04052024_040433.xml","form_type":"4"}},{"id":1546814,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T16:55:52.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9671643,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for (i) $2.5879 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares. The Reporting Person (\"Dr. Tananbaum\") is the sole managing member of FCM IV and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum disclaims the existence of a \"group.\" Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010434","document":"form4-04052024_040433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010434/form4-04052024_040433.xml","form_type":"4"}},{"id":1791745,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":110068,"kind":"organization","name":"FS Development Holdings II, LLC","position":2,"cik":"0001822712","reported_name":"FS Development Holdings II, LLC","relationship":{"ten_percent_owner":true}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T21:22:32.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":9.8,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-23-042108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000114036123042108/form4.xml","form_type":"4"}},{"id":1791744,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":110068,"kind":"organization","name":"FS Development Holdings II, LLC","position":2,"cik":"0001822712","reported_name":"FS Development Holdings II, LLC","relationship":{"ten_percent_owner":true}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T21:22:32.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":5.21,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001140361-23-042108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000114036123042108/form4.xml","form_type":"4"}},{"id":1791743,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":110068,"kind":"organization","name":"FS Development Holdings II, LLC","position":2,"cik":"0001822712","reported_name":"FS Development Holdings II, LLC","relationship":{"ten_percent_owner":true}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T21:22:32.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a \"Company Stock Option\") that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":1.87,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001140361-23-042108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000114036123042108/form4.xml","form_type":"4"}},{"id":1791742,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":110068,"kind":"organization","name":"FS Development Holdings II, LLC","position":2,"cik":"0001822712","reported_name":"FS Development Holdings II, LLC","relationship":{"ten_percent_owner":true}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-31T21:22:32.000Z","date":"2023-08-31","kind":"other","planned":false,"acquired":true,"shares":1000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, Merger Sub merged with and into the Issuer pursuant to Section 251(h) of the Delaware General Corporation Law, and each share of common stock of Merger Sub issued and outstanding immediately before the Effective Time automatically converted into and became one share of common stock, par value $0.0001 of the Issuer (representing 1,000 shares in the aggregate), with the Issuer surviving as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, Merger Sub merged with and into the Issuer pursuant to Section 251(h) of the Delaware General Corporation Law, and each share of common stock of Merger Sub issued and outstanding immediately before the Effective Time automatically converted into and became one share of common stock, par value $0.0001 of the Issuer (representing 1,000 shares in the aggregate), with the Issuer surviving as a wholly owned subsidiary of Parent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are beneficially owned by Parent. Parent is wholly owned by Foresite Capital Opportunity Fund V, L.P. Dr. Tananbaum is the managing member of Foresite Capital Opportunity Management V, LLC, which is the general partner of Foresite Capital Opportunity Fund V, L.P. Dr. Tananbaum may be deemed to have a pecuniary interest in the shares beneficially owned by Parent."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001140361-23-042108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000114036123042108/form4.xml","form_type":"4"}},{"id":1791741,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":110068,"kind":"organization","name":"FS Development Holdings II, LLC","position":2,"cik":"0001822712","reported_name":"FS Development Holdings II, LLC","relationship":{"ten_percent_owner":true}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"ten_percent_owner":true}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"ten_percent_owner":true}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-31T21:22:32.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16813146,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated July 16, 2023, by and among Pardes Biosciences, Inc. (the \"Issuer\"), MediPacific, Inc. (\"Parent\") and MediPacific Sub, Inc. (\"Purchaser\"), a wholly-owned subsidiary of Parent, pursuant to which Purchaser completed a tender offer (the \"Offer\") for shares of the Issuer, $0.0001 par value per share, and thereafter merged with and into the Issuer (the \"Merger\") effective as of August 31, 2023 (the \"Effective Time\"). In accordance with the terms of the Merger Agreement, at the Effective Time, the 16,813,146 shares beneficially owned by the Reporting Persons were automatically cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated July 16, 2023, by and among Pardes Biosciences, Inc. (the \"Issuer\"), MediPacific, Inc. (\"Parent\") and MediPacific Sub, Inc. (\"Purchaser\"), a wholly-owned subsidiary of Parent, pursuant to which Purchaser completed a tender offer (the \"Offer\") for shares of the Issuer, $0.0001 par value per share, and thereafter merged with and into the Issuer (the \"Merger\") effective as of August 31, 2023 (the \"Effective Time\"). In accordance with the terms of the Merger Agreement, at the Effective Time, the 16,813,146 shares beneficially owned by the Reporting Persons were automatically cancelled for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consisted of shares beneficially owned by FS Development Holdings II, LLC, Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC and Foresite Capital Fund V, L.P., and of which Dr. Tananbaum may be deemed to have had a pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-042108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000114036123042108/form4.xml","form_type":"4"}},{"id":1826911,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":1,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":3,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":4,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-19T14:54:37.000Z","date":"2023-07-17","kind":"purchase","planned":false,"acquired":true,"shares":176550,"price":2.97,"value":524353.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1385825,"source":{"system":"sec-edgar","filing":"0001209191-23-042720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000120919123042720/doc4.xml","form_type":"4"}},{"id":1826910,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":1,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":3,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":4,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-19T14:54:37.000Z","date":"2023-07-17","kind":"purchase","planned":false,"acquired":true,"shares":523450,"price":2.97,"value":1554646.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":4108796,"source":{"system":"sec-edgar","filing":"0001209191-23-042720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000120919123042720/doc4.xml","form_type":"4"}},{"id":1869101,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T20:14:20.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continued service to the Issuer on each applicable vesting date, the option vests as to 1/12 of the total award on each monthly anniversary of the Grant Date; provided, however, that notwithstanding the monthly vesting schedule, the options shall vest in full upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the next annual meeting of the stockholders."}],"balance_after":37500,"derivative":{"exercise_price":1.87,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-033684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000120919123033684/doc4.xml","form_type":"4"}},{"id":1898235,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T17:49:25.000Z","date":"2023-05-08","kind":"purchase","planned":false,"acquired":true,"shares":229044,"price":2.8,"value":641323.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":520711,"source":{"system":"sec-edgar","filing":"0001209191-23-028537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123028537/doc4.xml","form_type":"4"}},{"id":1898234,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T17:49:25.000Z","date":"2023-05-08","kind":"purchase","planned":false,"acquired":true,"shares":1550956,"price":2.8,"value":4342676.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. The Reporting Person (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":3525957,"source":{"system":"sec-edgar","filing":"0001209191-23-028537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123028537/doc4.xml","form_type":"4"}},{"id":1923465,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":1,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":2,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-07T01:08:36.000Z","date":"2023-04-05","kind":"purchase","planned":false,"acquired":true,"shares":773952,"price":1.5,"value":1160928.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On April 5, 2023, Foresite Capital Opportunity Fund V, L.P. (\"Capital Opportunity Fund V L.P.\") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\") is the general partner of Capital Opportunity Fund V L.P. Each of FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":8773134,"source":{"system":"sec-edgar","filing":"0001213900-23-028117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000121390023028117/ownership.xml","form_type":"4"}},{"id":1923461,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":1,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-07T01:08:12.000Z","date":"2023-04-05","kind":"purchase","planned":false,"acquired":true,"shares":773952,"price":1.5,"value":1160928.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On April 5, 2023, Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\") purchased 773,952 shares of the Issuer's Common Stock at an aggregate price of approximately $1.50 per share, or $1,160,928 in the aggregate, in open market purchases. Foresite Capital Management V, LLC (\"FCMVLLC\") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":13583762,"source":{"system":"sec-edgar","filing":"0001213900-23-028116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000121390023028116/ownership.xml","form_type":"4"}},{"id":2000066,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T14:50:23.000Z","date":"2023-02-17","kind":"other","acquired":true,"shares":1100000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 17, 2023, the Issuer completed the acquisition of Kinnjiu Biompharma, Inc. (the \"Kinnjiu Acquisition\"). Foresite Capital Fund V, L.P. (\"Fund V\") was a shareholder of Kinnjiu Biompharma, Inc. and, as a result of the Kinnjiu Acquisition, Fund V received a combination of cash and 1,100,000 shares of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Received in exchange for 17,500,000 shares of Kinnjiu Biopharma, Inc. in connection with the Kinnjiu Acquisition. The number of shares received was determined based on a volume weighted average price per share of $6.7757."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for 17,500,000 shares of Kinnjiu Biopharma, Inc. in connection with the Kinnjiu Acquisition. The number of shares received was determined based on a volume weighted average price per share of $6.7757."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Fund V. Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. The Reporting Person (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1975001,"source":{"system":"sec-edgar","filing":"0001209191-23-011566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123011566/doc4.xml","form_type":"4"}},{"id":2072732,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":1,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":3,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":4,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T16:24:38.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":250000,"price":5,"value":1250000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1209275,"source":{"system":"sec-edgar","filing":"0001209191-23-000204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000120919123000204/doc4.xml","form_type":"4"}},{"id":2072731,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":1,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":3,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":4,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T16:24:38.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":250000,"price":5,"value":1250000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":3585346,"source":{"system":"sec-edgar","filing":"0001209191-23-000204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000120919123000204/doc4.xml","form_type":"4"}},{"id":2095553,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":1,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":2,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":3,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-05T21:24:15.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":637420,"price":0.85,"value":541807.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On December 1, 2022, Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\") purchased 637,420 shares of the Issuer's Common Stock at an aggregate price of approximately $0.85 per share, or $541,807 in the aggregate, in open market purchases. Foresite Capital Management V, LLC (\"FCMVLLC\") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":12809810,"source":{"system":"sec-edgar","filing":"0001213900-22-077637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000121390022077637/ownership.xml","form_type":"4"}},{"id":2231541,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T17:00:43.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 13, 2022 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date."}],"balance_after":20250,"derivative":{"exercise_price":8.38,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0001209191-22-037021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919122037021/doc4.xml","form_type":"4"}},{"id":2235441,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:33:46.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continued service to the Issuer on each applicable vesting date, the option vests as to 1/12 of the total award on each monthly anniversary of the Grant Date; provided, however, that notwithstanding the monthly vesting schedule, the options shall vest in full upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the next annual meeting of the stockholders."}],"balance_after":37500,"derivative":{"exercise_price":5.21,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-22-035918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000120919122035918/doc4.xml","form_type":"4"}},{"id":2235440,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:17:45.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in substantially equal monthly installments over three years, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":75000,"derivative":{"exercise_price":9.8,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-035869","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000120919122035869/doc4a.xml","form_type":"4/A","original_submission_date":"2021-12-28"}},{"id":2455985,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T21:30:19.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":4941250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC (\"FSD Holdings II\"). Each of Foresite Capital Management V, LLC (\"FCMVLLC\"), Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\"), Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\"), Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC (\"FSD Holdings II\"). Each of Foresite Capital Management V, LLC (\"FCMVLLC\"), Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\"), Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\"), Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC (\"FSD Holdings II\"). Each of Foresite Capital Management V, LLC (\"FCMVLLC\"), Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\"), Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\"), Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC (\"FSD Holdings II\"). Each of Foresite Capital Management V, LLC (\"FCMVLLC\"), Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\"), Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\"), Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4941250},"source":{"system":"sec-edgar","filing":"0000899243-21-050105","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321050105/doc4a.xml","form_type":"4/A","original_submission_date":"2021-12-28"}},{"id":2455984,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T21:30:19.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":4941250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC (\"FSD Holdings II\"). Each of Foresite Capital Management V, LLC (\"FCMVLLC\"), Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\"), Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\"), Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC (\"FSD Holdings II\"). Each of Foresite Capital Management V, LLC (\"FCMVLLC\"), Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\"), Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\"), Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":4941250,"source":{"system":"sec-edgar","filing":"0000899243-21-050105","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321050105/doc4a.xml","form_type":"4/A","original_submission_date":"2021-12-28"}},{"id":2457701,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-28T21:30:18.000Z","date":"2021-12-23","kind":"grant","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest in substantially equal monthly installments over three years, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission"}],"balance_after":75000,"derivative":{"exercise_price":9.8,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-21-049928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321049928/doc4.xml","form_type":"4"}},{"id":2457700,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:30:18.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":4873750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4873750},"source":{"system":"sec-edgar","filing":"0000899243-21-049928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321049928/doc4.xml","form_type":"4"}},{"id":2457699,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:30:18.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":7759072,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, 4,237,940 shares and 1,273,577 shares of Series A Preferred Stock of the target company in the business combination (formerly known as Pardes Biosciences, Inc.), held, respectively, by Capital Fund V L.P. and Opportunity Fund V L.P., were converted into 5,966,140 and 1,792,932 shares of common stock, respectively, of the Issuer. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, 4,237,940 shares and 1,273,577 shares of Series A Preferred Stock of the target company in the business combination (formerly known as Pardes Biosciences, Inc.), held, respectively, by Capital Fund V L.P. and Opportunity Fund V L.P., were converted into 5,966,140 and 1,792,932 shares of common stock, respectively, of the Issuer. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":7759072,"source":{"system":"sec-edgar","filing":"0000899243-21-049928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321049928/doc4.xml","form_type":"4"}},{"id":2457698,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:30:18.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":4873750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":4873750,"source":{"system":"sec-edgar","filing":"0000899243-21-049928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321049928/doc4.xml","form_type":"4"}},{"id":2457697,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:30:18.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each of Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\") and Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\"), the sole shareholders of FS Development Holdings II, LLC (\"FSD Holdings II\"), were issued 500,000 shares of common stock obtained in private placement of public securities on December 23, 2021. Foresite Capital Management V, LLC (\"FCMVLLC\") and Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\") are general partners, respectively, of Capital Fund V L.P. and Opportunity Fund V L.P. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of each of FCMVLLC and FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\") and Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\"), the sole shareholders of FS Development Holdings II, LLC (\"FSD Holdings II\"), were issued 500,000 shares of common stock obtained in private placement of public securities on December 23, 2021. Foresite Capital Management V, LLC (\"FCMVLLC\") and Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\") are general partners, respectively, of Capital Fund V L.P. and Opportunity Fund V L.P. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of each of FCMVLLC and FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0000899243-21-049928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000089924321049928/doc4.xml","form_type":"4"}},{"id":2459296,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":2,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":4,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T21:52:41.000Z","date":"2021-12-22","kind":"purchase","acquired":true,"shares":325000,"price":10,"value":3250000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each of Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\") and Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") purchased 162,500 shares of the Issuer's Class A Common Stock in a block trade at $10 per share on December 22, 2021. Foresite Capital Management V, LLC (\"FCMVLLC\") and Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\") are general partners, respectively, of Capital Fund V L.P. and Opportunity Fund V L.P. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of each of FCMVLLC and FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of the Issuer's Class A Common Stock were reclassified as common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Foresite Capital Fund V, L.P. (\"Capital Fund V L.P.\") and Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V L.P.\") purchased 162,500 shares of the Issuer's Class A Common Stock in a block trade at $10 per share on December 22, 2021. Foresite Capital Management V, LLC (\"FCMVLLC\") and Foresite Capital Opportunity Management V, LLC (\"FCOMVLLC\") are general partners, respectively, of Capital Fund V L.P. and Opportunity Fund V L.P. Each of FCMVLLC, FCOMVLLC and Dr. Tananbaum, in his capacity as managing member of each of FCMVLLC and FCOMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of the Issuer's Class A Common Stock were reclassified as common stock."}],"balance_after":325000,"source":{"system":"sec-edgar","filing":"0001213900-21-067341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581754/000121390021067341/ownership.xml","form_type":"4"}},{"id":2526411,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":1,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":2,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":3,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":5,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T20:17:40.000Z","date":"2021-11-01","kind":"other","acquired":true,"shares":8276,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares received by the James B. Tananbaum and Dana Shonfeld Tananbaum Family Trust pursuant to pro rata distributions by Fund III and FCM III, for no consideration, of shares of the Issuer's Common Stock to their respective partners or members, as applicable. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by a family trust for which Mr. Tananbaum is a trustee. Each of the Reporting Persons disclaims the existence of a \"group\" and, other than Mr. Tananbaum, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8276,"source":{"system":"sec-edgar","filing":"0001209191-21-062697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919121062697/doc4.xml","form_type":"4"}},{"id":2526410,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":1,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":2,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":3,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":5,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T20:17:40.000Z","date":"2021-11-01","kind":"other","acquired":false,"shares":1954904,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 1, 2021, Foresite Capital Fund III, L.P. (\"Fund III\") distributed, for no consideration, 1,954,904 shares of the Issuer's Common Stock (the \"Fund III Shares\") to its limited partners and to Foresite Capital Management III, LLC (\"FCM III\"), the general partner of Fund III, representing each such partner's pro rata interest in such Fund III Shares. On the same date, FCM III distributed, for no consideration, the Fund III Shares it received in the distribution by Fund III to its members, representing each such member's pro rata interest in such Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Fund III. FCM III is the general partner of Fund III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\") is the sole managing member of FCM III and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-062697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919121062697/doc4.xml","form_type":"4"}},{"id":2547293,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T20:15:57.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":17245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date."}],"balance_after":17245,"derivative":{"exercise_price":3.8,"expiration_date":"2021-10-03","underlying":"Common Stock","underlying_shares":17245},"source":{"system":"sec-edgar","filing":"0000899243-21-039457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924321039457/doc4.xml","form_type":"4"}},{"id":2670413,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-14T22:55:33.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on June 11, 2022, subject to Dr. Tananbaum's continued service through the applicable vesting date."}],"balance_after":20512,"source":{"system":"sec-edgar","filing":"0001104659-21-080931","document":"tm2119549-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000110465921080931/tm2119549-22_4seq1.xml","form_type":"4"}},{"id":2670412,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-14T22:55:33.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":348125,"price":0.001,"value":348.125,"ownership":{"direct":false,"nature":"By Foresite Capital Opportunity Fund V, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Foresite V and Foresite Opportunity each acquired 348,125 shares of Class A common stock from the Issuer, at a price of $0.001 per share, immediately prior to the closing of the Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Foresite Capital Fund IV, L.P. (\"Foresite IV\") and may be deemed to have sole voting and dispositive power over shares held by Foresite IV. Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Foresite Capital Fund V, L.P. (\"Foresite V\") and Foresite Capital Opportunity Fund V, L.P. (\"Foresite Opportunity\") and may be deemed to have sole voting and dispositive power over shares held by Foresite V and Foresite Opportunity. Dr. Tananbaum is the sole managing member of FCM IV and FCM V and may be deemed to have sole voting and dispositive power over share held by Foresite IV, Foresite V, and Foresite Opportunity. Each of FCM IV, FCM V, Foresite Opportunity, and Dr. Tananbaum disclaims beneficial ownership of shares held by Foresite IV, Foresite V, and Foresite Opportunity except to the extent of any pecuniary interest therein."}],"balance_after":1598125,"source":{"system":"sec-edgar","filing":"0001104659-21-080931","document":"tm2119549-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000110465921080931/tm2119549-22_4seq1.xml","form_type":"4"}},{"id":2670411,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-14T22:55:33.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":1250000,"price":10,"value":12500000.0,"ownership":{"direct":false,"nature":"By Foresite Capital Opportunity Fund V, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Foresite V and Foresite Opportunity each purchased 1,250,000 shares of Class A common stock from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Foresite Capital Fund IV, L.P. (\"Foresite IV\") and may be deemed to have sole voting and dispositive power over shares held by Foresite IV. Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Foresite Capital Fund V, L.P. (\"Foresite V\") and Foresite Capital Opportunity Fund V, L.P. (\"Foresite Opportunity\") and may be deemed to have sole voting and dispositive power over shares held by Foresite V and Foresite Opportunity. Dr. Tananbaum is the sole managing member of FCM IV and FCM V and may be deemed to have sole voting and dispositive power over share held by Foresite IV, Foresite V, and Foresite Opportunity. Each of FCM IV, FCM V, Foresite Opportunity, and Dr. Tananbaum disclaims beneficial ownership of shares held by Foresite IV, Foresite V, and Foresite Opportunity except to the extent of any pecuniary interest therein."}],"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0001104659-21-080931","document":"tm2119549-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000110465921080931/tm2119549-22_4seq1.xml","form_type":"4"}},{"id":2670410,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-14T22:55:33.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":348125,"price":0.001,"value":348.125,"ownership":{"direct":false,"nature":"Foresite Capital Fund V, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Foresite V and Foresite Opportunity each acquired 348,125 shares of Class A common stock from the Issuer, at a price of $0.001 per share, immediately prior to the closing of the Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Foresite Capital Fund IV, L.P. (\"Foresite IV\") and may be deemed to have sole voting and dispositive power over shares held by Foresite IV. Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Foresite Capital Fund V, L.P. (\"Foresite V\") and Foresite Capital Opportunity Fund V, L.P. (\"Foresite Opportunity\") and may be deemed to have sole voting and dispositive power over shares held by Foresite V and Foresite Opportunity. Dr. Tananbaum is the sole managing member of FCM IV and FCM V and may be deemed to have sole voting and dispositive power over share held by Foresite IV, Foresite V, and Foresite Opportunity. Each of FCM IV, FCM V, Foresite Opportunity, and Dr. Tananbaum disclaims beneficial ownership of shares held by Foresite IV, Foresite V, and Foresite Opportunity except to the extent of any pecuniary interest therein."}],"balance_after":2342061,"source":{"system":"sec-edgar","filing":"0001104659-21-080931","document":"tm2119549-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000110465921080931/tm2119549-22_4seq1.xml","form_type":"4"}},{"id":2670409,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":25096,"kind":"person","name":"Tananbaum James B.","position":1,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-14T22:55:33.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":1250000,"price":10,"value":12500000.0,"ownership":{"direct":false,"nature":"Foresite Capital Fund V, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Foresite V and Foresite Opportunity each purchased 1,250,000 shares of Class A common stock from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Foresite Capital Fund IV, L.P. (\"Foresite IV\") and may be deemed to have sole voting and dispositive power over shares held by Foresite IV. Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Foresite Capital Fund V, L.P. (\"Foresite V\") and Foresite Capital Opportunity Fund V, L.P. (\"Foresite Opportunity\") and may be deemed to have sole voting and dispositive power over shares held by Foresite V and Foresite Opportunity. Dr. Tananbaum is the sole managing member of FCM IV and FCM V and may be deemed to have sole voting and dispositive power over share held by Foresite IV, Foresite V, and Foresite Opportunity. Each of FCM IV, FCM V, Foresite Opportunity, and Dr. Tananbaum disclaims beneficial ownership of shares held by Foresite IV, Foresite V, and Foresite Opportunity except to the extent of any pecuniary interest therein."}],"balance_after":1993936,"source":{"system":"sec-edgar","filing":"0001104659-21-080931","document":"tm2119549-22_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000110465921080931/tm2119549-22_4seq1.xml","form_type":"4"}}],"next_cursor":"2021-06-14T22:55:33.000000Z,2670409"}